Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
16 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Imunon, Inc.’s names, not what it holds today.
Patents granted
16
16 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
13
2 of them in 2025
Names they are printed under
4
a former name, a subsidiary, its own name
By yearGrantedApplications published
'02'03'04'05'06'07'13'14'15'16'17'18'19'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name4 counted
Celsion Corporation a former name
US, as the owner printed on each patent
6 publishedCLSN Laboratories, Inc. a subsidiary
US, as the owner printed on each patent
4 publishedCELSION CORPORATION a former name
named as the applicant on its applications, in US
2 publishedIMUNON, INC. its own name
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Apr 9, 2019 | 10,251,901 | Thermosensitive nanoparticle formulations and method of making the same | Pharmaceuticals | Celsion Corporation |
| Nov 28, 2017 | 9,827,331 | Nucleic acid-lipopolymer compositions | Pharmaceuticals | CLSN Laboratories, Inc. |
| Oct 18, 2016 | 9,468,687 | Immuno gene therapy for treatment of cancer and hyperproliferative diseases | Pharmaceuticals | CLSN Laboratories, Inc. |
| Feb 9, 2016 | 9,254,334 | Polyamine derivatives | Pharmaceuticals | CLSN Laboratories, Inc. |
| Sep 29, 2015 | 9,144,546 | Nucleic acid-lipopolymer compositions | Pharmaceuticals | CLSN Laboratories, Inc. |
| Jan 13, 2015 | 8,932,638 | Polyamine derivatives | Pharmaceuticals | CLSN Laboratories, Inc. |
| Dec 2, 2014 | 8,900,621 | Polyamine derivatives | Pharmaceuticals | CLSN Laboratories, Inc. |
| Feb 4, 2014 | 8,642,074 | Thermosensitive liposomes containing therapeutic agents | Pharmaceuticals | Celsion Corporation |
| Oct 25, 2005 | 6,958,075 | Device and method for treatment of tissue adjacent a bodily conduit by thermocompression | Medical technology | Celsion Corporation |
| Oct 19, 2004 | 6,807,446 | Monopole phased array thermotherapy applicator for deep tumor therapy | Medical technology | Celsion Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 6, 2025 | 2025/0339510 | POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME | Pharmaceuticals | IMUNON, INC. |
| Jul 3, 2025 | 2025/0213679 | POLYNUCLEOTIDE VACCINES AND METHODS OF USING THE SAME | Pharmaceuticals | CELSION CORPORATION |
| Oct 25, 2018 | 2018/0303957 | NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS | Pharmaceuticals | CLSN Laboratories, Inc. |
| Mar 23, 2017 | 2017/0080003 | THERMOSENSITIVE NANOPARTICLE FORMULATIONS AND METHOD OF MAKING THE SAME | Pharmaceuticals | CELSION CORPORATION · patent 10,251,901 granted from it |
| Nov 17, 2016 | 2016/0331686 | Compositions and Methods for Yeast Extracellular Vesicles as Delivery Systems | Pharmaceuticals | CLSN Laboratories, Inc. |
| Aug 25, 2016 | 2016/0243256 | NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS | Pharmaceuticals | CLSN Laboratories, Inc. · patent 9,827,331 granted from it |
| Apr 9, 2015 | 2015/0099000 | Polyamine Derivatives | Pharmaceuticals | CLSN Laboratories, Inc. · patent 9,254,334 granted from it |
| Sep 5, 2013 | 2013/0230457 | Thermosensitive Nanoparticle Formulations and Method of Making The Same | Pharmaceuticals | Celsion Corporation |
| Apr 5, 2007 | 2007/0077230 | Method for the pre-conditioning/fixation and treatment of diseases with heat activation/release with thermo-activated drugs and gene products | Medical technology | Celsion Corporation · patent 8,476,242 granted from it |
| Sep 28, 2006 | 2006/0216275 | Apparatus and method for pre-conditioning/fixation and treatment of disease with heat activation/release with thermoactivated drugs and gene products | Medical technology | Celsion Corporation · patent 8,765,116 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.